期刊文献+

临床药师的介入对化疗相关性恶心呕吐预防用药方案依从性的影响 被引量:1

Effect of intervention of clinical pharmacists on compliance of medication regimen for the prevention of chemotherapy-induced nausea and vomiting
原文传递
导出
摘要 目的调查化疗相关性恶心呕吐(CINV)预防用药的现状,探讨临床药师的介入对CINV预防用药方案依从性的影响。方法将临沧市人民医院肿瘤科2017年11月—2018年1月期间化疗的119例患者作为对照组;2018年3—5月期间化疗的97例患者作为观察组。按照《抗肿瘤药物CINV预防用药方案》进行评价,比较临床药师介入后对照组与观察组CINV预防用药方案依从情况。结果对照组的CINV预防用药方案依从率为23.5%,观察组的CINV预防用药方案依从率为69.1%,2组比较差异有统计学意义(P<0.05)。结论临床药师的介入使医院肿瘤科CINV预防用药方案依从性得到了大幅提高。
作者 王慧铃 冯金象 张光云 段宏民 潘兴 施文勇 WANG Hui-ling;FENG Jin-xiang;ZHANG Guang-yun;DUAN Hong-min;PAN Xing;SHI Wen-yong(Department of Clinical Pharmacy,the People’s Hospital of Lin Cang,Yunnan Lincang 677000,China;Department of Oncology,the People’s Hospital of Lin Cang,Yunnan Lincang 677000,China)
出处 《临床药物治疗杂志》 2020年第11期59-62,共4页 Clinical Medication Journal
  • 相关文献

参考文献4

二级参考文献42

  • 1杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 3NCCN Clinical Practice Guidelines in Oncology: Antiemesis. version 1. 2014[EB/OL] .[2014-02-25]. http://www. nccn. orgl professionalsl physician_glsl pdfl antiemesis. pdf.
  • 4MASCC/ESMO. Antiemetic Guidelines 2013[EB/OL].[2014- 02-25]. http://www. mascc. orgl antiemetic-guidelines; 2013 MASccTM?.
  • 5Gralla RJ, Osoba D, Krismg, et al. Recommendations for the use of anti emetics : evidence-based, clinical practice guidelines[J] .J Clin Oncol, 1999, 17(9): 2971-2994.
  • 6徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014—02-25].http://www.csao].cn/bencandy.php?aid=6246.
  • 7Apfel CC, Heidrich FM,Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting[J] . BrJ Anaesth, 2012, 109(5): 742-753.
  • 8Warr DG, Grunberg SM, Gralla RJ, et al. The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials[J]. EurJ Cancer, 2005, 41(9): 1278-1285.
  • 9Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron[J]. Ann Oncol, 2003, 14 ( 10) : 1570-1577.
  • 10Eisenberg P, Figueroa- VadilloJ, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel SsH'L, receptor antagonist[J]. Cancer, 2003, 98( 11) : 2473-2482.

共引文献431

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部